SCHEMBL5590249

SCHEMBL5590249

CCCCc1cc(OC(=O)O)c(O)c(OCCC)c1CCCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
THRA P10827 3/20 0.35
THRB P10828 3/20 0.35
ALOX5 P09917 6/20 0.34
PTGES O14684 2/20 0.34
TOP2A P11388 1/20 0.34
PTPN1 P18031 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589432 0.96 PPARG (0.41) PPARGPPARDPPARATHRATHRB
SCHEMBL5586654 0.95 ALOX5 (0.40) PPARGPPARDPPARATHRATHRB
SCHEMBL5589997 0.95 ALOX5 (0.40) PPARGPPARDPPARATHRATHRB
SCHEMBL5588172 0.95 ALOX5 (0.40) PPARGPPARDPPARATHRATHRB
SCHEMBL5588351 0.95 ALOX5 (0.40) PPARGPPARDPPARATHRATHRB
SCHEMBL5589138 0.95 ALOX5 (0.40) PPARGPPARDPPARATHRATHRB
SCHEMBL5586676 0.95 THRA (0.40) PPARGPPARDPPARATHRATHRB
SCHEMBL5588293 0.94 THRA (0.41) PPARGPPARDPPARATHRATHRB
SCHEMBL5588111 0.94 THRA (0.41) PPARGPPARDPPARATHRATHRB
SCHEMBL5586707 0.94 THRA (0.41) PPARGPPARDPPARATHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PPARG 3592/4885PPARD 3634/4885PPARA 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.